|
Table 1: General characteristic of the sample according to sex. |
|||
|
Female n (%) |
Male n (%) |
Total n (%) |
|
|
Clinical characteristics |
|||
|
Secondary education |
12 (32.4) |
18 (50.0) |
30 (41.1) |
|
Urban origin |
34 (91.9) |
34 (94.4) |
68 (93.2) |
|
Sedentarism |
33 (89.2) |
28 (77.8) |
61 (83.6) |
|
Current smokers |
3 (8.1) |
6 (16.7) |
9 (12.3) |
|
Ex-smokers |
17 (45.9) |
13 (36.1) |
30 (41.1) |
|
Cardiovascular disease (FH) |
21 (56.8) |
14 (38.9) |
35 (47.9) |
|
Hypertension |
32 (86.5) |
29 (80.6) |
61 (83.6) |
|
Diabetes mellitus |
11 (29.7) |
12 (33.3) |
23 (31.5) |
|
Dyslipidemia |
12 (32.4) |
17 (47.2) |
29 (39.7) |
|
Prior ACS* |
20 (54.1) |
30 (83.3) |
50 (68.5) |
|
Drug use |
|||
|
Nitrates* |
15 (40.5) |
25 (69.4) |
40 (54.8) |
|
ACEi or ARB |
27 (73.0) |
27 (75.0) |
54 (74.0) |
|
Single antiplatelet therapy |
13 (35.1) |
11 (30.6) |
24 (32.9) |
|
Dual antiplatelet therapy |
16 (43.2) |
21 (58.3) |
37 (50.7) |
|
Statins* |
13 (35.1) |
27 (75.0) |
40 (54.8) |
|
Antidiabetics |
9 (24.3) |
9 (25.0) |
18 (24.7) |
|
SGLT2i |
4 (10.8) |
3 (8.3) |
7 (9.6) |
|
Age (years)‡ |
60.4 ± 7.1 |
58.7 ± 8.3 |
59.5 ± 7.7 |
|
Total |
37 (50.7) |
36 (49.3) |
73 (100.0) |
|
ACEi = Angiotensin-Converting Enzyme inhibitor. ACS = Acute Coronary Syndrome. ARB = Angiotensin Receptor Blocker. FH = Family History. SGLT2i = Sodium-GLucose coTransporter-2 inhibitors. ‡ Data indicate mean ± standard deviation. |
|||